Cheat sheet

ANCC PMHNP-BC Cheat Sheet

Practice this exam

Scientific Foundation

  • 22% of exam
  • Pathophysiology Pharmacology Neurobiology Psychogenomics Physical assessment

Advanced Practice Skills

  • 27% of exam
  • Clinical interviewing Mental status exam Risk assessment Screening tools Recovery planning

Diagnosis and Treatment

  • 22% of exam
  • DSM-5-TR diagnosis Differential diagnosis Psychopharmacology Complementary care Treatment planning

Psychotherapy and Related Theories

  • 11% of exam
  • Therapy modalities Behavior change Developmental theory Family systems Therapeutic alliance

Ethics, Legal Principles, and Cultural Care

  • 17% of exam
  • Patient rights Confidentiality Ethical principles Cultural humility Advocacy

Quick Facts

  • Credential PMHNP-BC
  • Total questions 175
  • Scored questions 150
  • Pretest questions 25 unscored
  • Exam time 3.5 hours
  • Passing score 350 scaled
  • Testing vendor Prometric
  • Testing window 120 days
  • Credential term 5 years
  • Clinical minimum 500 supervised hours
  • Current fees $220-$395 by membership

Serotonin Syndrome vs NMS SC

Serotonin syndrome

  • Clonus and hyperreflexia
  • Rapid onset
  • GI symptoms common

NMS

  • Lead-pipe rigidity
  • Slower onset
  • Elevated CK common
  • Neuromuscular pattern separates them

Adverse Effect Triage SC

  • Clonus and hyperreflexia → Suspect serotonin syndrome ( Stop serotonergic agents )
  • Fever and severe rigidity → Suspect malignant syndrome ( Urgent medical treatment )
  • Painful sustained contraction → Treat acute dystonia ( Protect airway )
  • Distressing inner restlessness → Assess for akathisia ( Do not mislabel agitation )
  • Delayed involuntary movements → Assess tardive dyskinesia ( Use structured scale )
  • Coarse tremor and ataxia → Assess lithium toxicity ( Check level and kidneys )
  • Rash with mucosal lesions → Stop culprit medication ( Urgent medical evaluation )
  • Fever with neutropenia → Escalate infection care ( Review clozapine management )

Neurotransmitters and Dopamine Pathways SC

  • Mesolimbic pathway Positive psychotic symptoms
  • Mesocortical pathway Negative and cognitive symptoms
  • Nigrostriatal pathway Movement and EPS effects
  • Tuberoinfundibular pathway Prolactin regulation
  • Serotonin Mood, anxiety, sleep, appetite
  • Norepinephrine Arousal, attention, energy
  • Dopamine Reward, motivation, movement
  • GABA Primary inhibitory signaling
  • Glutamate Primary excitatory signaling
  • Acetylcholine Attention, memory, learning
  • HPA axis Coordinates stress response

Positive vs Negative Symptoms SC

Positive

  • Hallucinations
  • Delusions
  • Disorganized speech

Negative

  • Avolition
  • Anhedonia
  • Diminished expression
  • Added versus diminished function

Psychotropic Mechanism Essentials SC

  • SSRIs Inhibit serotonin reuptake
  • SNRIs Inhibit serotonin and norepinephrine reuptake
  • Bupropion Inhibits norepinephrine and dopamine reuptake
  • Mirtazapine Blocks alpha-2, H1, serotonin receptors
  • Benzodiazepines Modulate GABA-A receptors
  • Typical antipsychotics Primarily block D2 receptors
  • Atypical antipsychotics Modulate dopamine and serotonin
  • Partial D2 agonists Stabilize dopamine signaling
  • Stimulants Increase catecholamine signaling
  • Cholinesterase inhibitors Reduce acetylcholine breakdown
  • CYP inhibitor May raise substrate levels
  • CYP inducer May lower substrate levels

High-Risk Adverse Syndromes SC

  • Serotonin syndrome Clonus, hyperreflexia, fever, diaphoresis
  • Neuroleptic malignant syndrome Rigidity, fever, elevated CK
  • Acute dystonia Sustained painful muscle contractions
  • Akathisia Distressing inner restlessness
  • Drug-induced parkinsonism Rigidity, tremor, bradykinesia
  • Tardive dyskinesia Delayed involuntary movements
  • Lithium toxicity GI upset, coarse tremor, ataxia
  • SJS or TEN Rash plus mucosal involvement
  • Severe neutropenia Infection risk; urgent evaluation
  • Anticholinergic toxicity Delirium, dryness, retention, hyperthermia
  • Valproate pregnancy risk Major fetal harm risk

CAGE Alcohol Screen AD

  • Cut down, Annoyed, Guilty, Eye-opener
  • Cut down Criticism annoyed Feel guilty Morning eye-opener

Mood vs Affect AD

Mood

  • Patient reports it
  • Sustained internal state
  • Quote patient when useful

Affect

  • Clinician observes it
  • Range and reactivity
  • Congruence matters
  • Mood reported; affect observed

Suicide Safety Triage AD

  • Current plan, intent, means → Emergency evaluation now ( Maintain immediate safety )
  • Recent attempt disclosed → Escalate level of care ( Assess medical needs )
  • Intoxication impairs assessment → Stabilize and reassess ( Risk remains dynamic )
  • Command hallucinations threaten harm → Protect and evaluate urgently ( Assess ability to resist )
  • Means remain accessible → Create lethal-means plan ( Use collaborative counseling )
  • No imminent danger → Build collaborative safety plan ( Document risk formulation )
  • Outpatient disposition chosen → Arrange timely follow-up ( Specify crisis resources )

Mental Status Examination AD

  • Appearance Grooming, dress, apparent age
  • Behavior Activity, cooperation, eye contact
  • Speech Rate, volume, fluency, latency
  • Mood Patient-reported emotional state
  • Affect Observed emotional expression
  • Thought process Organization and associations
  • Thought content Beliefs, preoccupations, safety themes
  • Perception Hallucinations and illusions
  • Cognition Orientation, attention, memory
  • Insight Understanding illness and needs
  • Judgment Anticipating choices and consequences

ASEPTIC Mental Status AD

  • Appearance, Speech, Emotion, Perception, Thought, Insight, Cognition
  • Appearance behavior Speech Mood affect Perception Thought Insight judgment Cognition

Screening and Assessment Tools AD

  • PHQ-9 Depression symptom severity
  • GAD-7 Generalized anxiety symptom severity
  • C-SSRS Suicidal ideation and behavior
  • SAFE-T Structures suicide evaluation
  • AIMS Tardive dyskinesia monitoring
  • CIWA-Ar Alcohol withdrawal severity
  • COWS Opioid withdrawal severity
  • AUDIT Hazardous alcohol use
  • DAST Drug-related problem screening
  • CAM Delirium detection
  • MoCA Brief cognitive screening
  • Vanderbilt scales Child ADHD symptom ratings

Suicide and Violence Formulation AD

  • Prior attempt Key historical suicide risk
  • Current ideation Ask frequency and intensity
  • Plan Assess specificity and lethality
  • Intent Assess expected action
  • Means access Assess firearms and medications
  • Dynamic factors Intoxication, agitation, acute loss
  • Protective factors Do not erase acute risk
  • Collateral information Clarifies baseline and access
  • Safety plan Steps through lethal-means safety
  • Level of care Match acuity and supports
  • Follow-up Specify timing and responsibility

Medication Monitoring Map AD

  • Lithium baseline Renal, thyroid, calcium, pregnancy
  • Lithium levels Use timed trough concentrations
  • Valproate CBC, liver tests, pregnancy
  • Carbamazepine CBC, liver tests, sodium
  • Antipsychotic metabolic Weight, pressure, glucose, lipids
  • Antipsychotic movement Structured movement assessment
  • Clozapine ANC per current labeling
  • Stimulants Pressure, pulse, growth, misuse
  • SSRIs and SNRIs Suicidality, sodium, bleeding, activation
  • Urine immunoassay Treat result as presumptive
  • Pharmacogenomics Adjunct, not diagnostic replacement

DIG FAST Mania DI

  • Distractibility, Indiscretion, Grandiosity, Flight, Activity, Sleep, Talk
  • Distractible Risky behavior Grandiose Flight of ideas Goal activity Sleep decreased Talkative

Mania vs Hypomania DI

Mania

  • Marked impairment
  • Hospitalization may occur
  • Psychosis may occur

Hypomania

  • Observable functional change
  • No marked impairment
  • No psychosis
  • Severity outranks duration alone

Diagnostic Duration Picker DI

  • Psychosis under one month → Consider brief psychosis ( Minimum one day )
  • Psychosis one to six months → Consider schizophreniform disorder ( Exclude mood and substances )
  • Disturbance at least six months → Consider schizophrenia ( Check active-phase criteria )
  • Trauma symptoms under one month → Consider acute stress ( Minimum three days )
  • Trauma symptoms exceed one month → Consider PTSD ( Confirm full clusters )
  • Elevation lasts four days → Consider hypomania ( No marked impairment )
  • Elevation lasts one week → Consider mania ( Hospitalization overrides duration )

Diagnostic Time Anchors DI

  • Major depression Two weeks; five symptoms
  • Mania One week or hospitalization
  • Hypomania Four consecutive days
  • Generalized anxiety Six months excessive anxiety
  • Acute stress disorder Three days through one month
  • PTSD Symptoms exceed one month
  • Brief psychotic disorder One day under one month
  • Schizophreniform disorder One through six months
  • Schizophrenia Continuous disturbance six months
  • Persistent depressive disorder Two years in adults
  • Cyclothymic disorder Two years in adults

SIGECAPS Depression DI

  • Sleep, Interest, Guilt, Energy, Concentration, Appetite, Psychomotor, Suicide
  • Sleep change Interest loss Guilt Low energy Poor concentration Appetite change Psychomotor change Suicidality

Delirium vs Neurocognitive Disorder DI

Delirium

  • Acute and fluctuating
  • Attention impaired
  • Medical cause likely

Neurocognitive disorder

  • Usually gradual decline
  • Attention often preserved early
  • Independence may decline
  • Acute inattention signals delirium

High-Yield Diagnostic Discriminators DI

  • Delirium Acute fluctuating inattention
  • Major neurocognitive disorder Decline impairs independence
  • Bipolar I Mania defines diagnosis
  • Bipolar II Hypomania plus major depression
  • Schizoaffective disorder Psychosis persists without mood episode
  • OCD Usually ego-dystonic symptoms
  • OCPD Usually ego-syntonic traits
  • ADHD Childhood onset; multiple settings
  • Substance-induced disorder Symptoms track substance exposure
  • Normal grief Waves with preserved self-worth
  • Major depression Pervasive symptoms and impairment

Obsession vs Delusion DI

Obsession

  • Intrusive recurring thought
  • Usually unwanted
  • Often resisted

Delusion

  • Fixed false belief
  • Held despite evidence
  • Insight often absent
  • Assess conviction and insight

Evidence-Based Treatment Pairings DI

  • OCD ERP plus serotonergic medication
  • PTSD Trauma-focused psychotherapy
  • Borderline personality Dialectical behavior therapy
  • Chronic insomnia CBT-I first-line
  • Panic disorder CBT plus SSRI or SNRI
  • Acute mania Mood stabilizer or antipsychotic
  • Bipolar depression Use bipolar-specific treatment
  • Treatment-resistant schizophrenia Consider clozapine after adequate trials
  • Severe catatonia Benzodiazepine or ECT
  • ADHD Stimulant or approved nonstimulant
  • Major depression Match treatment to severity

Substance-Related Care DI

  • Alcohol withdrawal Benzodiazepines reduce seizure risk
  • Suspected Wernicke Give thiamine promptly
  • Hypoglycemia Never delay emergent glucose
  • Opioid overdose Ventilation plus naloxone
  • Opioid use disorder Buprenorphine, methadone, or naltrexone
  • Alcohol use disorder Match approved medication individually
  • Benzodiazepine dependence Avoid abrupt discontinuation
  • Stimulant intoxication Reduce stimulation; manage complications
  • Nicotine dependence Medication plus behavioral support
  • Positive immunoassay Confirm when clinically consequential

OARS Interviewing Skills PS

  • Open questions, Affirmations, Reflections, Summaries
  • Ask openly Affirm strengths Reflect meaning Summarize change talk

Transference vs Countertransference PS

Transference

  • Patient reactions
  • Past patterns enter therapy
  • Explore therapeutically

Countertransference

  • Clinician reactions
  • May distort judgment
  • Use reflection and supervision
  • Direction identifies the concept

Psychotherapy Modality Picker PS

  • Obsessions and compulsions → Choose ERP ( Prevent ritual response )
  • Chronic emotion dysregulation → Choose DBT ( Balance acceptance and change )
  • Insomnia maintains itself → Choose CBT-I ( Target sleep behaviors )
  • Ambivalence blocks change → Choose motivational interviewing ( Elicit change talk )
  • Interpersonal loss or transition → Choose interpersonal therapy ( Target current relationships )
  • Trauma drives symptoms → Choose trauma-focused therapy ( Assess readiness and safety )
  • Family interactions maintain symptoms → Choose family therapy ( Map relational patterns )

Psychotherapy Modality Map PS

  • CBT Links thoughts, feelings, behaviors
  • DBT Balances acceptance and change
  • ERP Exposure while preventing rituals
  • Motivational interviewing Elicits intrinsic change language
  • Interpersonal therapy Targets relationships and role transitions
  • Psychodynamic therapy Explores unconscious relational patterns
  • Supportive therapy Strengthens coping and functioning
  • Family systems Treats relational interaction patterns
  • Group therapy Uses shared therapeutic factors
  • CBT-I Restructures insomnia-maintaining behaviors
  • Trauma-focused therapy Processes trauma safely

CBT vs DBT PS

CBT

  • Restructures biased thoughts
  • Changes behavior patterns
  • Uses collaborative experiments

DBT

  • Balances acceptance and change
  • Builds four skill modules
  • Targets behavioral hierarchy
  • DBT adds dialectical skills

Therapeutic Process Concepts PS

  • Alliance Bond, goals, tasks
  • Transference Patient projects prior relationship patterns
  • Countertransference Clinician reactions require reflection
  • Boundary Protects therapeutic relationship
  • Validation Acknowledges understandable experience
  • Open question Invites elaboration
  • Reflection Returns meaning or feeling
  • Cognitive distortion Biased thinking pattern
  • Negative reinforcement Removal increases behavior
  • Universality Others share similar struggles
  • Exposure Approaches feared stimuli gradually

UARC Capacity Elements ET

  • Understand, Appreciate, Reason, Communicate
  • Understand information Appreciate consequences Reason about options Communicate a choice

Capacity vs Competency ET

Capacity

  • Clinical determination
  • Decision-specific
  • May fluctuate

Competency

  • Court determination
  • Legal status
  • Jurisdiction controls
  • Clinicians assess capacity

Confidentiality Disclosure Picker ET

  • Valid authorization covers request → Disclose authorized scope ( Verify identity and expiration )
  • Treatment disclosure is permitted → Share clinically necessary information ( Follow organizational policy )
  • Serious threat emerges → Apply state protection law ( Document consultation and action )
  • Reportable abuse suspected → Follow state mandate ( Report reasonable suspicion )
  • Substance-use records requested → Apply Part 2 ( Check current exceptions )
  • Psychotherapy notes requested → Apply special protections ( Separate from progress notes )
  • Legal demand arrives → Seek legal review ( Do not release reflexively )
  • Minor requests confidential care → Check state rules ( Explain privacy limits )

Ethics and Decision Capacity ET

  • Autonomy Respect informed patient choices
  • Beneficence Promote patient welfare
  • Nonmaleficence Avoid preventable harm
  • Justice Distribute care fairly
  • Veracity Communicate truthfully
  • Fidelity Keep professional commitments
  • Capacity Clinical and decision-specific
  • Competency Legal court determination
  • Informed consent Disclosure, understanding, voluntariness, authorization
  • Least restrictive care Preserve liberty when safe
  • Substituted judgment Apply patient's known preferences

Confidentiality and Legal Boundaries ET

  • HIPAA treatment use Disclosure may not need authorization
  • Minimum necessary Limit non-treatment disclosures
  • Psychotherapy notes Receive special HIPAA protection
  • Part 2 records Apply federal substance-use protections
  • Duty to protect Follow applicable state law
  • Mandatory reporting Requirements vary by jurisdiction
  • Minor consent Follow state-specific rules
  • Involuntary treatment Criteria vary by jurisdiction
  • Scope of practice State law controls authority
  • Telehealth practice Patient location governs licensure
  • Controlled substances Apply federal and state rules

Cultural and Recovery-Oriented Care ET

  • Cultural humility Practice lifelong self-reflection
  • Cultural formulation Elicit identity and explanatory model
  • Qualified interpreter Avoid family interpretation
  • Social determinants Assess structural barriers
  • Trauma-informed care Safety, choice, collaboration, empowerment
  • Recovery model Hope, agency, meaningful life
  • Shared decision-making Integrate evidence and preferences
  • Identity-affirming care Use respectful patient language
  • Spiritual assessment Explore meaning and supports
  • Structural competence Recognize systemic health effects
  • Advocacy Address access and inequity

Common Traps

Pretest Items Look Identical

  • Twenty-five items are unscored ≠ Answer every question

Scaled Score Is Not Percentage

  • Passing score is 350 ≠ Raw score gets converted

Screening Is Not Diagnosis

  • Tools estimate symptom burden ≠ Clinical assessment confirms diagnosis

Contracts Are Not Safety Plans

  • No-harm promises provide little protection ≠ Build actionable safety steps

Mood Is Not Affect

  • Mood comes from patient ≠ Affect comes from observation

Capacity Is Not Competency

  • Capacity is clinical ≠ Competency is legal

Law Is Jurisdiction-Specific

  • Check current state requirements ≠ Avoid universal legal deadlines

Avoid Antidepressant Monotherapy

  • Screen for bipolar disorder ≠ Use bipolar-specific treatment

Do Not Delay Glucose

  • Give thiamine promptly ≠ Treat hypoglycemia immediately

Clozapine REMS Was Removed

  • FDA ended REMS requirements ≠ Continue label-based safety monitoring

Genomics Remains Adjunctive

  • Results may inform prescribing ≠ They do not diagnose

Last Minute

  • 1. Memorize five domain weights
  • 2. Separate mood from affect
  • 3. Know dopamine pathways
  • 4. Differentiate serotonin syndrome and NMS
  • 5. Review psychosis duration anchors
  • 6. Compare mania and hypomania
  • 7. Match screening tools correctly
  • 8. Prioritize suicide safety
  • 9. Recognize lithium toxicity
  • 10. Review metabolic monitoring
  • 11. Match disorders to therapies
  • 12. Separate capacity from competency
  • 13. Apply jurisdiction-specific law
  • 14. Answer every exam item

ANCC Psychiatric-Mental Health Nurse Practitioner

  • Practice Questions 118 questions Study Guide 42 topics Cheat Sheet 177 facts Flashcards 50 cards Shorts 2 short s Videos 1 video Blogs 1 blog Free CE Podcast